Severe COVID-19 and Flu Linked to Increased Lung Cancer Risk, But Vaccination Offers Protection

A recent study from UVA Health has revealed a concerning link between severe respiratory infections like COVID-19 and influenza and an increased risk of developing lung cancer months or even years after recovery. But, the research also offers a hopeful message: vaccination significantly reduces this risk.

How Viral Infections Prime Lungs for Cancer

Researchers at the University of Virginia’s Beirne B. Carter Center for Immunology Research and UVA Comprehensive Cancer Center discovered that severe COVID-19 and flu infections can “reprogram” immune cells within the lungs, creating an environment more conducive to tumor growth. This reprogramming leads to chronic inflammation, which can persist long after the initial infection has cleared.

“A bad case of COVID or flu can leave the lungs in a long-lasting ‘inflamed’ state that makes it easier for cancer to take hold later,” explained Jie Sun, PhD, co-director of UVA’s Carter Center and a member of UVA’s Division of Infectious Diseases and International Health .

Study Findings: Mice and Human Data

The study involved both laboratory experiments with mice and analysis of data from human patients. Mice that experienced severe lung infections were more likely to develop lung cancer and had a lower survival rate. Analysis of patient data showed a significant association between prior COVID-19 hospitalization and an increased incidence of lung cancer – approximately a 1.24 times higher risk .

Specifically, the research identified changes in two key immune cells – neutrophils and macrophages – as well as alterations in the cells lining the bronchi and alveoli. These changes contribute to the inflammatory environment that supports cancer cell growth .

The Protective Power of Vaccination

The good news is that vaccination against respiratory viruses appears to mitigate these harmful effects. Vaccines reduce the severity of infection, thereby preventing the immune changes that can lead to cancer development. “The encouraging news is that vaccination largely prevents those harmful changes for cancer growth in the lung,” Dr. Sun stated .

Recommendations for Monitoring and Early Detection

Based on these findings, researchers are urging doctors to closely monitor patients who have recovered from severe COVID-19, flu, or pneumonia, particularly those with existing risk factors such as smoking. This may include periodic lung screenings, such as CT scans, to facilitate early detection of any potential changes .

Key Takeaways

• Severe COVID-19 and influenza can increase the long-term risk of lung cancer.
• Viral infections can alter immune cells in the lungs, creating a pro-cancer environment.
• Vaccination significantly reduces the risk by lessening the severity of infection.
• Patients recovering from severe respiratory infections should be monitored for early signs of lung cancer.

Understanding the connection between viral infections and lung cancer is crucial for improving prevention and early detection strategies, ultimately increasing the chances of successful treatment and survival.